文献速递肿瘤 PET/CT神经核医学

使用18F-氟胆碱PET/CT早期检测胶质瘤复发:GliReDe先导研究

Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study.
PubMed 文献 · Clin Nucl Med · 2022-07-15

该先导研究前瞻性纳入21例胶质瘤全切除后首次MRI可疑或不确定复发患者,共24次检查,评估18F-氟胆碱PET/CT早期诊断复发的价值。PET/CT阳性23例(3例假阳性),MRI阳性15例(1例假阳性),MRI假阴性6例,PET/CT无假阴性;PET/CT准确率87.5%,MRI为70.8%。作者认为18F-氟胆碱PET/CT有助于提高MRI不确定复发时的诊断信心,以避免延迟诊断。

要点

  • 18F-氟胆碱PET/CT在MRI可疑复发时无假阴性,准确率87.5%高于MRI的70.8%。
  • 两种影像联合评估较单独PET/CT未见优势,一致性低(κ=0.135;P=0.375)。
  • SUVmax与肿瘤/本底比值均与复发相关,曲线下面积分别为0.844(P=0.033)和0.869(P=0.022)。

核心结论

  • 18F-氟胆碱PET/CT有助于提高MRI对复发不确定病例的诊断信心,以避免延迟诊断。

研究设计与样本

  • 前瞻性纳入既往胶质瘤全切除、首次MRI可疑或不确定复发的患者,行18F-氟胆碱PET/CT检查。
  • 对18F-氟胆碱PET/CT与多模态MRI进行独立和联合评估,将检查分类为肿瘤复发阳性或阴性。
  • 最终诊断(复发与否)通过组织学确认或临床与影像随访获得。
  • 分析SUVmax及肿瘤/本底比值与进展的关系、各影像技术的诊断性能及两者一致性(κ Cohen)。
  • 共评估21例患者的24次检查。

主要发现

  • 24次检查中诊断复发20例。
  • PET/CT阳性23例(3例假阳性),MRI阳性15例(1例假阳性),MRI假阴性6例。
  • 18F-氟胆碱PET/CT无假阴性。
  • PET/CT准确率为87.5%,MRI准确率为70.8%。
  • 两种技术联合评估较单独PET/CT结果未见任何优势;两种影像技术一致性低(κ=0.135;P=0.375)。

关键数值与推荐

  • PET/CT阳性23例中3例为假阳性,MRI阳性15例中1例为假阳性。
  • MRI假阴性6例,18F-氟胆碱PET/CT无假阴性。
  • PET/CT准确率87.5% vs MRI准确率70.8%。
  • 两种影像技术一致性κ=0.135(P=0.375)。
  • SUVmax预测复发的曲线下面积为0.844(P=0.033),肿瘤/本底比值为0.869(P=0.022)。

临床怎么用

  • 作者认为,在MRI对复发不确定的病例中,18F-氟胆碱PET/CT有助于提高诊断信心,以避免延迟诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to analyze the usefulness of 18 F-fluorocholine PET/CT in the early diagnosis of tumor recurrence, increasing the diagnosis confidence of MRI. METHODS: Patients with a previous gross total resection of glioma and the first suspicious or doubtful for recurrence MRI were prospectively included and subjected to 18 F-fluorocholine PET/CT. An independent and combined assessment of 18 F-fluorocholine PET/CT and multimodal MRI was performed classifying the studies as positive or negative for tumor recurrence. Final diagnosis (recurrence or not) was obtained by histological confirmation or clinical and imaging follow-up. The relation of SUV max and tumor-to-background ratio with progression, the diagnostic performance of imaging techniques, and their concordance (κ Cohen) were analyzed. RESULTS: Twenty-four studies on 21 patients were assessed. Recurrence was diagnosed in 20 cases. PET/CT was positive in 23 cases (3 false positive), whereas MRI was positive in 15 cases (1 false positive). MRI was false negative in 6 cases. There was no false negative on 18 F-fluorocholine PET/CT. Accuracy of PET/CT versus MRI was 87.5% and 70.8%, respectively. The combined evaluation of both techniques did not show any advantage with respect to PET/CT results alone. The concordance between both imaging techniques was low (κ = 0.135; P = 0.375). SUV max and tumor-to-background ratio were related to recurrence (areas under the curve of 0.844 [ P = 0.033] and 0.869 [ P = 0.022], respectively). CONCLUSIONS: 18 F-fluorocholine PET/CT was helpful for increasing the diagnostic confidence in the cases of MRI doubtful for recurrence in order to avoid a delayed diagnosis.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. García Vicente AM, Amo-Salas M, Sandoval Valencia H, et al. Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study. Clin Nucl Med. 2022. PMID: 35835092. doi:10.1097/RLU.0000000000004329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。